|Application ||WB, IHC-P, IF, E|
|Dilution||ELISA (1:10000), IF (1:100-1:500), IHC-P (10 µg/ml), WB (1:500-1:1000) ,|
|Other Names||Suppressor of tumorigenicity 14 protein, 220.127.116.11, Matriptase, Membrane-type serine protease 1, MT-SP1, Prostamin, Serine protease 14, Serine protease TADG-15, Tumor-associated differentially-expressed gene 15 protein, ST14, PRSS14, SNC19, TADG15|
|Target/Specificity||ST14 Antibody detects endogenous levels of total ST14 protein.|
|Reconstitution & Storage||Store at -20°C for up to one year.|
|Precautions||ST14 / Matriptase Antibody (aa10-59) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||PRSS14, SNC19, TADG15|
|Function||Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing.|
|Cellular Location||Membrane; Single-pass type II membrane protein|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing.
Lin C.Y.,et al.J. Biol. Chem. 274:18231-18236(1999).
Takeuchi T.,et al.Proc. Natl. Acad. Sci. U.S.A. 96:11054-11061(1999).
Yamaguchi N.,et al.Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
Tanimoto H.,et al.Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
Cao J.,et al.Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.